Does TREPROSTINIL Cause Therapy cessation? 743 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 743 reports of Therapy cessation have been filed in association with TREPROSTINIL (TYVASO). This represents 0.8% of all adverse event reports for TREPROSTINIL.
743
Reports of Therapy cessation with TREPROSTINIL
0.8%
of all TREPROSTINIL reports
39
Deaths
260
Hospitalizations
How Dangerous Is Therapy cessation From TREPROSTINIL?
Of the 743 reports, 39 (5.2%) resulted in death, 260 (35.0%) required hospitalization, and 16 (2.2%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 743 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
ISOTRETINOIN (633)
SECUKINUMAB (620)
Which TREPROSTINIL Alternatives Have Lower Therapy cessation Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE